Concepedia

Federico Rodríguez-Pérez

FR

Statistics

Publications

11

Citations

2K

H-Index

11

Active since

1992

Affiliations

University of Puerto Rico, Medical Sciences Campus(Current)

Kaohsiung Medical University Chung-Ho Memorial Hospital

Pinnacle Clinical Research

Texas Liver Institute

Newcastle upon Tyne Hospitals NHS Foundation Trust

Federico Rodríguez-Pérez is an author at University of Puerto Rico, Medical Sciences Campus specializing in viral hepatitis, medicine, and antiviral therapy.

Publications per year

1992–2020

11

Publications

11

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

, , +8

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

, , +12

Glecaprevir/pibrentasvir for 8 weeks in treatment-naïve patients with chronic HCV genotypes 1–6 and compensated cirrhosis: The EXPEDITION-8 trial

Robert S. Brown, Lino Rodrigues, Vladimir Chulanov et al. · Journal of Hepatology · 2019 · 155 citations

, , +17

PHARMACOLOGIC TREATMENT OF PORTAL HYPERTENSION

Federico Rodríguez-Pérez, Roberto J. Groszmann · Gastroenterology Clinics of North America · 1992 · 50 citations

, , +12

ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients Receiving Stable Opioid Substitution Treatment: Pooled Analysis of Efficacy and Safety in Phase 2 and Phase 3 Trials

Massimo Puoti, C. Cooper, Sulkowski et al. · Queen Mary Research Online (Queen Mary University of London) · 2014 · 22 citations

, , +14

1–5 of 11